Mapmygenome Revenue and Competitors
Estimated Revenue & Valuation
- Mapmygenome's estimated annual revenue is currently $22M per year.
- Mapmygenome's estimated revenue per employee is $148,500
Employee Data
- Mapmygenome has 148 Employees.
- Mapmygenome grew their employee count by -2% last year.
Mapmygenome's People
Name | Title | Email/Phone |
---|---|---|
1 | VP - Genetic Counseling | Reveal Email/Phone |
2 | AVP - HR & Admin | Reveal Email/Phone |
3 | Senior Scientific Officer | Reveal Email/Phone |
4 | Junior Product Manager | Reveal Email/Phone |
5 | Senior Marketing Manager | Reveal Email/Phone |
6 | Lead Generation Manager | Reveal Email/Phone |
7 | Product Manager | Reveal Email/Phone |
8 | Operations Manager | Reveal Email/Phone |
9 | Reginal Sales Head | Reveal Email/Phone |
10 | Genetic Counselor | Reveal Email/Phone |
Mapmygenome Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $10.8M | 80 | -1% | N/A | N/A |
#2 | $17.1M | 127 | 3% | N/A | N/A |
#3 | $16.3M | 121 | 10% | N/A | N/A |
#4 | $2.6M | 27 | -13% | $3M | N/A |
#5 | $17.8M | 132 | 10% | N/A | N/A |
#6 | $18.4M | 136 | 11% | N/A | N/A |
#7 | $29.1M | 196 | 0% | N/A | N/A |
#8 | $6.4M | 53 | 6% | N/A | N/A |
#9 | $14M | 104 | 5% | N/A | N/A |
#10 | $6.2M | 51 | 0% | N/A | N/A |
What Is Mapmygenome?
Mapmygenome India Limited is a molecular diagnostics company for people who are proactive about their health. By combining genetic report and health history with genetic counseling, Mapmygenome provides actionable steps for individuals and their physicians towards a healthier life. Mapmygenome started as India's pioneering Genomics Company with a vision to provide "Better Health for Indians using technology." Products and Services We have a range of products and services spanning several verticals in healthcare. Personal Genomics Molecular Diagnostics DNA Forensics Brain Wellness Our most popular services include: Genomepatriâ„¢: A simple, saliva-based test to decode your DNA and predict genetic risk for 120+ diseases, traits, drug responses, inherited conditions, and carrier statuses. Genomepatri Cardioâ„¢: Genomics-based predictive risk assessment and management panel for cardiovascular diseases and diabetes. SugarGeneâ„¢: Personal genomics service to assess the genetic risk of type 2 diabetes and obesity, nutrigenetics, and management options. Genomepatri Fit: DNA-based nutrition and fitness planner. Genomepatri Brainâ„¢: wellness prognostics with predictive assessment for diseases such as Alzheimer's, ADHD, Bipolar Disorder, Parkinson's, and Schizophrenia. Genomepatri Gynaecâ„¢: DNA-based women's wellness assessment. Genomepatri Oncoâ„¢: Cancer panel covering over 17 different cancers with prognostics for early detection and risk mitigation. Whole Exome sequencing: It provides sequence information for around 21000 genes in the human exome, including all coding regions of DNA Whole Genome sequencing: It is a comprehensive sequencing service, covering 95-98% of the DNA sequence of the human genome. WebNeuroâ„¢: A 30-minute screening test to assess cognitive strengths and weaknesses of individuals. MyCalmBeatâ„¢: Urban Pranayamâ„¢ kiosk to de-stress through paced breathing.
keywords:N/AN/A
Total Funding
148
Number of Employees
$22M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Mapmygenome News
GX Sciences, , AGS, , Pathway Genomics, , Fitgenes, , LIFEdata, , DNAfit, , HealthCodes DNA, , Mapmygenome, , Strategic Lab Partners, , uBiome,...
Ancestry, Gene By Gene, Mapmygenome, Color Genomics Futura Genetics, Positive Biosciences, Helix OpCo LLC, Pathway Genomics, MyHeritage Ltd.,...
BENGALURU, India, March 2, 2022 /PRNewswire/ -- Mapmygenome India opened its Genomics Experience Center in Bengaluru on March 1.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $16.4M | 148 | 8% | N/A |
#2 | N/A | 149 | 10% | N/A |
#3 | $23.9M | 150 | 4% | N/A |
#4 | $13.6M | 150 | -1% | N/A |
#5 | $12M | 151 | -1% | N/A |